|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.37 USD | +0.22% |
|
-0.79% | +23.24% |
| 16/05 | Argus Downgrades Catalent to Sell From Buy | MT |
| 14/05 | Novo Nordisk Selling $5 Billion in Bonds to Back Catalent Deal | MT |
May 3 (Reuters) - Catalent and parent of Wegovy producer Novo Nordisk have received a request for additional information from the U.S. Federal Trade Commission related to their merger.
In February, Novo Holdings had agreed to buy Catalent for $16.5 billion to boost Wegovy supply. (Reporting by Bhanvi Satija in Bengaluru; Editing by Shilpi Majumdar)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 903.3 DKK | -1.05% | +2.28% | 593B | ||
| 55.37 USD | +0.22% | -0.79% | 10B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +23.24% | 10B | |
| +32.09% | 694B | |
| +29.39% | 593B | |
| -1.34% | 371B | |
| +20.34% | 331B | |
| +7.39% | 290B | |
| +14.25% | 239B | |
| -3.03% | 209B | |
| +10.02% | 209B | |
| +8.49% | 169B |
CATALENT, INC. 